This topic contains a solution. Click here to go to the answer

Author Question: A patient will begin using a transdermal preparation of a muscarinic antagonist for overactive ... (Read 56 times)

james9437

  • Hero Member
  • *****
  • Posts: 568
A patient will begin using a transdermal preparation of a muscarinic antagonist for overactive bladder (OAB).
 
  The nurse teaches the patient what to do if side effects occur. Which statement by the patient indicates the need for further teaching?
  a. I can use sugar-free gum for dry mouth.
  b. I may need laxatives for constipation.
  c. I should keep the site covered to prevent other people from getting the medicine.
  d. I will take Benadryl for any itching caused by a local reaction to the patch.

Question 2

An older adult patient who lives alone and is somewhat forgetful has an overactive bladder and reports occasional constipation. Which treatment will the nurse anticipate for this patient?
 
  a. Behavioral therapy
  b. Oxybutynin (Ditropan XL) extended-release tablets
  c. Oxybutynin (Oxytrol) transdermal patch
  d. Percutaneous tibial nerve stimulation (PTNS)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

brittiany.barnes

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

ANS: D
Benadryl is an antihistamine, and even though it is not classified as a muscarinic antagonist, it has anticholinergic effects. Giving it with a muscarinic antagonist greatly enhances these effects, so it should not be used. Muscarinic antagonists cause dry mouth, and patients should be taught to use sugar-free gum or candies to help with this. Muscarinic antagonists can cause constipation, and laxatives may be used. Medication applied topically can be transferred to others who come in contact with the skin, so the site should be covered.

Answer to Question 2

ANS: C
The transdermal patch is applied weekly and may be the best option for a patient who is more likely to forget to take a daily medication. The transdermal preparation has fewer side effects than the systemic dose so is less likely to increase this patient's constipation. Behavioral therapy should be tried first in patients who can participate. However, it is not the best option for a forgetful patient who lives alone, because it requires scheduled voiding and timing of fluid intake. The extended-release tablets must be given daily, and this patient may not remember to take them. PTNS is used after behavioral and drug therapies have failed.




james9437

  • Member
  • Posts: 568
Reply 2 on: Jul 23, 2018
Gracias!


6ana001

  • Member
  • Posts: 311
Reply 3 on: Yesterday
Excellent

 

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

For a complete list of videos, visit our video library